Related references
Note: Only part of the references are listed.Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer
Houssein Chhouri et al.
CANCERS (2023)
Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method
Yomogi Sato et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids
Amira Abugomaa et al.
FRONTIERS IN PHARMACOLOGY (2023)
Organoid Models for Infectious Disease
Sarah E. Blutt et al.
ANNUAL REVIEW OF MEDICINE (2022)
Distribution of histopathologic types of primary pulmonary neoplasia in dogs and outcome of affected dogs: 340 cases (2010-2019)
Jourdan B. McPhetridge et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2022)
Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs
Shingo Maeda et al.
SCIENTIFIC REPORTS (2022)
The Obscure Potential of AHNAK2
Mohamed Zardab et al.
CANCERS (2022)
Generation of Human Lung Organoid Cultures from Healthy and Tumor Tissue to Study Infectious Diseases
Lorena Salgueiro et al.
JOURNAL OF VIROLOGY (2022)
Retrospective analysis of efficacy and safety of oral paclitaxel for treatment of various cancers in dogs (2017-2021)
Hyung-Kyu Chae et al.
VETERINARY MEDICINE AND SCIENCE (2022)
AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas
Meng Xu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2022)
Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method
Mohamed Elbadawy et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Predictive biomarkers for response to trametinib in non-small cell lung cancer
Palak R. Parekh et al.
TUMOR BIOLOGY (2022)
Establishment of a direct 2.5D organoid culture model using companion animal cancer tissues
Amira Abugomaa et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
The potential of organoids in toxicologic pathology: role of toxicologic pathologists in in vitro chemical hepatotoxicity assessment
Toshinori Yoshida et al.
JOURNAL OF TOXICOLOGIC PATHOLOGY (2022)
Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids
Mohamed Elbadawy et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
MEK inhibitors for the treatment of non-small cell lung cancer
Jing Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The NRG3/ERBB4 signaling cascade as a novel therapeutic target for canine glioma
Shunsuke Noguchi et al.
EXPERIMENTAL CELL RESEARCH (2021)
Clinical application of a lung cancer organoid (tumoroid) culture system
Etsuko Yokota et al.
NPJ PRECISION ONCOLOGY (2021)
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial
A. Camerini et al.
ESMO OPEN (2021)
Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism
Mohamed Elbadawy et al.
CANCER BIOLOGY & THERAPY (2021)
Role of multidrug resistance-associated proteins in cancer therapeutics: past, present, and future perspectives
Ahmed Elfadadny et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)
Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer
Ruoshi Shi et al.
CLINICAL CANCER RESEARCH (2020)
Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model
Mohamed Elbadawy et al.
BIOMATERIALS (2020)
Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
Hiroki Yamazaki et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2020)
Antiproliferative and Antimetastatic Effects of Praeruptorin C on Human Non-Small Cell Lung Cancer through Inactivating ERK/CTSD Signalling Pathways
Chien-Ming Liu et al.
MOLECULES (2020)
Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma
Ines Pulido et al.
CANCER RESEARCH (2020)
Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
Zhichao Li et al.
ISCIENCE (2020)
Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture
Amira Abugomaa et al.
SCIENTIFIC REPORTS (2020)
A Contemporary Retrospective Study of Survival in Dogs With Primary Lung Tumors: 40 Cases (2005-2017)
Ruth J. Rose et al.
FRONTIERS IN VETERINARY SCIENCE (2020)
Update 2020: Management of Non-Small Cell Lung Cancer
Mariam Alexander et al.
LUNG (2020)
Clinical Development of BRAF plus MEK Inhibitor Combinations
Vivek Subbiah et al.
TRENDS IN CANCER (2020)
Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer
Sho Yoshimoto et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2020)
Mouse and human urothelial cancer organoids: A tool for bladder cancer research
Jasper Mullenders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Yahya Ashraf et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer
Kathryn E. Cronise et al.
MOLECULAR PHARMACOLOGY (2019)
Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture
Mohamed Elbadawy et al.
CANCER SCIENCE (2019)
Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma
Gwendolen Lorch et al.
CLINICAL CANCER RESEARCH (2019)
Long-term expanding human airway organoids for disease modeling
Norman Sachs et al.
EMBO JOURNAL (2019)
Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer
Misako Nagasaka et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells
Mitsuo Nishiyama et al.
CANCER SCIENCE (2018)
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Chiara Ambrogio et al.
CELL (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue
Kobe Reynders et al.
RADIATION ONCOLOGY (2018)
Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide
G. Polton et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis
Kosaku Nanki et al.
CELL (2018)
Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines
Kosei Sakai et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma
W. Zhang et al.
ONCOGENE (2017)
Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells
Tatsuya Usui et al.
CANCER SCIENCE (2017)
Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma
Hidenori Kusumoto et al.
CANCER SCIENCE (2017)
Lung organoids: current uses and future promise
Christina E. Barkauskas et al.
DEVELOPMENT (2017)
Modeling Development and Disease with Organoids
Hans Clevers
CELL (2016)
Review on EGFR Inhibitors: Critical Updates
Davinder Singh et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma
Bih-Rong Wei et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment
Tatsuya Usui et al.
STEM CELLS INTERNATIONAL (2016)
Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model
Vladimir Ermolayev et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Clinical effects of vinorelbine administration in the management of various malignant tumor types in dogs: 58 cases (1997-2012)
Raelene M. Wouda et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2015)
Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence
Ulrike Schick et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Characterization of HOX gene expression in canine mammary tumour cell lines from spontaneous tumours
P. DeInnocentes et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2015)
TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling
Lingyi Fu et al.
MOLECULAR CANCER (2014)
EGFR overexpression in canine primary lung cancer: pathogenetic implications and impact on survival
S. Sabattini et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2014)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Immunohistochemical Expression of HOXA-13 in Normal, Hyperplastic and Neoplastic Canine Prostatic Tissue
C. Palmieri et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2013)
MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib
Ming-Hung Huang et al.
MOLECULAR ONCOLOGY (2013)
Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line
Yong Yook Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition
Aidan G. Gilmartin et al.
CLINICAL CANCER RESEARCH (2011)
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Hidenori Fukuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
Roque Diaz et al.
BMC CANCER (2010)
Tyrosine Kinase Inhibitors in Veterinary Medicine
Cheryl A. London
TOPICS IN COMPANION ANIMAL MEDICINE (2009)
Palliative intravenous cisplatin treatment for concurrent peritoneal and pleural mesothelioma in a dog
Kyoung-Won Seo et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog
D McKillop et al.
XENOBIOTICA (2004)
Share Paper
